Uveitis Posterior
📧 Sign up to get email alerts when something new happens for Uveitis Posterior.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Frequency and Intensity of Inflammatory Relapses in Patients With Non-infectious Posterior Uveitis Treated With a Fluocinolone Acetonide Implant
This clinical trial update describes the frequency and intensity of inflammatory relapses in patients with noninfectious posterior uveitis t…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) [Phase 4]
Phase 4 trial update on Acthar Gel for inflammation of the eye's uvea, with terminated status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis [Phase 3]
Phase 3 trial evaluating suprachoroidal CLS-TA injection for non-infectious uveitis has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
Extension study update for patients with non-infectious uveitis who participated in CLS1001-301 (MAGNOLIA) has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis [Phase 3]
Phase 3 trial update for suprachoroidal CLS-TA injections in macular edema due to non-infectious uveitis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Study Assessing Double-masked Uveitis Treatment [Phase 3]
Phase 3 study of a double-masked treatment for posterior uveitis has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis [Phase 3]
Phase 3 trial evaluating LX211 for non-infectious uveitis has completed. The study examined posterior, intermediate, and pan-uveitis.